William Hildebrand to Peptides
This is a "connection" page, showing publications William Hildebrand has written about Peptides.
Connection Strength
3.523
-
NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors. Cancer Immunol Res. 2018 06; 6(6):636-644.
Score: 0.491
-
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer. Mol Cancer Ther. 2016 Feb; 15(2):313-22.
Score: 0.420
-
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. J Virol. 2014 Nov; 88(22):12992-3004.
Score: 0.383
-
TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):328-40.
Score: 0.313
-
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods. 2007 Jan 10; 318(1-2):47-58.
Score: 0.222
-
Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201. J Immunol Methods. 2006 Jul 31; 314(1-2):38-53.
Score: 0.217
-
The immune response under stress: the role of HSP-derived peptides. Trends Immunol. 2004 Aug; 25(8):427-33.
Score: 0.190
-
Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides. Front Immunol. 2020; 11:629399.
Score: 0.150
-
Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. Front Immunol. 2018; 9:886.
Score: 0.123
-
T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells. PLoS One. 2017; 12(11):e0188288.
Score: 0.120
-
The Intergenic Recombinant HLA-B*46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands. Cell Rep. 2017 05 16; 19(7):1394-1405.
Score: 0.116
-
Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics. 1997; 45(6):379-85.
Score: 0.113
-
The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference. J Immunol. 2016 Feb 15; 196(4):1480-7.
Score: 0.105
-
Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol. 2011 Oct-Dec; 30(5-6):312-27.
Score: 0.078
-
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. J Immunol. 2011 Feb 01; 186(3):1575-88.
Score: 0.074
-
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol. 2009 Jun 15; 182(12):7763-75.
Score: 0.067
-
Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics. 2006 Dec; 3(6):641-52.
Score: 0.056
-
Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. Biochemistry. 2005 Sep 20; 44(37):12491-507.
Score: 0.052
-
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci Adv. 2023 11 24; 9(47):eadj6367.
Score: 0.045
-
HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum Immunol. 2002 Apr; 63(4):248-55.
Score: 0.040
-
Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front Immunol. 2022; 13:835454.
Score: 0.040
-
Class I MHC expression in the yellow baboon. J Immunol. 2001 Mar 15; 166(6):3983-93.
Score: 0.038
-
Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med. 2011 Dec 07; 9:208.
Score: 0.020
-
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol. 2011 Jun 01; 186(11):6607-16.
Score: 0.019
-
Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity. World J Gastroenterol. 2010 Apr 28; 16(16):1953-69.
Score: 0.018
-
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing. J Immunol. 2006 Oct 15; 177(8):5088-97.
Score: 0.014